Chronos Archive seal
The Human Record

Frida Kahlo

Case HR-NI011 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
July 6, 1907 – July 13, 1954
Synthetic DOB
1989-07-06
Index visit
2026-09-17 at age 37
Synthetic MRN
HR-NI011-SYN

Teaching objective: Manage chronic pain after major trauma and childhood polio in a patient already on long-term opioid therapy, following the CDC 2022 opioid guideline: measure pain and function, build a nonopioid and rehabilitation plan, offer naloxone and other risk mitigation, and taper gradually and collaboratively rather than abruptly, while screening mood and treating post-traumatic ankle osteoarthritis on the CMID schedule.

Historical timeline

DateEventClaims
July 6, 1907Born in Coyoacán, Mexico City.CLM-0001
1913Polio at age six, leaving the right leg thinner and shorter.CLM-0003, CLM-0004
September 17, 1925Bus struck by a streetcar: pelvic, spinal, collarbone, rib, and right leg fractures.CLM-0005
1925 to 1926Began to paint while immobilized in bed.CLM-0006
After 1925Chronic pain, many operations, and about 25 corsets.CLM-0007, CLM-0009
1932Mother died.CLM-0012
1941Father died.CLM-0012
1944Stopped attending her classes at La Esmeralda because of limited mobility.CLM-0008
1950Nearly a year in hospital with an infection after a spinal graft.CLM-0010
1953Right leg amputated below the knee for threatened gangrene.CLM-0011
July 13, 1954Died at the Blue House, aged 47.CLM-0002

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Magdalena Carmen Frida Kahlo Calderón was born on July 6, 1907, in her parents' house in Coyoacán, Mexico City, now known as the Blue House, the daughter of Guillermo Kahlo and Matilde Calderón. confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
D Frida Kahlo died at the Blue House in Mexico City on July 13, 1954, at the age of 47.
Record the death as a fact without graphic detail.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
D In 1913, at the age of six, Kahlo fell ill with polio; afterward her right leg was thinner, slightly shorter, and less developed, with the foot turned outward, and her father encouraged cycling and swimming.
The contemporaneous diagnosis was polio; a retrospective analysis adds a congenital spinal anomaly.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 supports
R A neurologist's retrospective review proposes that Kahlo also had a congenital spinal anomaly (spina bifida).
Retrospective interpretation; kept off the active problem list.
possible Budrys V. Neurological deficits in the life and works of Frida Kahlo. Eur Neurol. 2006;55(1):4-10 supports
D On September 17, 1925, at 18, Kahlo was riding a bus that was struck by a streetcar; a metal handrail impaled her through the hip and fractured her pelvis, and she had three fractures of the spinal column, a fractured collarbone, two rib fractures, a dislocated right shoulder, and eleven fractures of the right leg with a dislocated foot.
The documented injuries behind the synthetic chronic pain diagnoses; stated without graphic detail.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 supports
D While immobilized for several months after the accident, Kahlo began to paint, using an easel adapted for painting in bed.
A documented strength: art as a way through prolonged pain and bed rest.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
D Kahlo lived with chronic pain for the rest of her life, underwent many operations, some with long convalescences and serious consequences, and used about 25 different corsets. confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 supports
D In 1944, because of increasingly limited mobility, Kahlo had to stop attending her classes at the La Esmeralda school of painting and sculpture, and some students continued to work with her at the Blue House.
The documented functional decline that anchors the index age.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
R Her pain has been interpreted retrospectively as including chronic neuropathic pain and central sensitization.
Modern pain-science interpretation; informs the synthetic multimodal plan.
probable Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 supports
Budrys V. Neurological deficits in the life and works of Frida Kahlo. Eur Neurol. 2006;55(1):4-10 supports
D In 1950 Kahlo spent nearly the whole year in hospital with an infection after a graft to her spinal column. confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
D In 1953 Kahlo's right leg was amputated below the knee because of the threat of gangrene. confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports
Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 supports
D Kahlo's father, Guillermo Kahlo, had epilepsy and died in 1941; her mother, Matilde Calderón, died in 1932.
The cited source does not give causes of death.
confirmed Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Chronic low back and pelvic pain after remote spinal and pelvic fractures and spinal surgery, with neuropathic features in the right leg; linked to the documented 1925 injuries active confirmed both_with_link CLM-0005, CLM-0007, CLM-0009
S Post-traumatic osteoarthritis of the right ankle and foot after multiple leg fractures and a foot dislocation active confirmed active CLM-0005
S Right leg weakness, atrophy, and shortening after childhood poliomyelitis; a congenital spinal anomaly has been proposed retrospectively active provisional both_with_link CLM-0003, CLM-0004
S Long-term opioid therapy for chronic pain, 60 MME a day at intake active confirmed active
S Vitamin D deficiency active confirmed active
S Acute viral upper respiratory infection (common cold), resolved without antibiotics resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-09-17 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-09-17 Creatinine [Mass/volume] in Serum or Plasma 0.72 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-09-17 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 110 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-09-17 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 18 ng/mL (low)
Reference 30-100 ng/mL
http://loinc.org · 62292-8
S 2026-09-17 Mean score [PEG] 7.3 http://loinc.org · 91147-9
S 2026-09-17 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 8 http://loinc.org · 44261-6
S 2026-10-01 Mean score [PEG] 7 http://loinc.org · 91147-9
S 2026-10-15 Mean score [PEG] 6 http://loinc.org · 91147-9
S 2026-10-15 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 2026-10-29 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-10-29 Mean score [PEG] 5.3 http://loinc.org · 91147-9
S 2026-10-29 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-10-08 Mean score [PEG] 7 http://loinc.org · 91147-9
S 2026-10-22 Mean score [PEG] 5.7 http://loinc.org · 91147-9
S 2026-10-22 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 2026-10-22 Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 http://loinc.org · 70274-6
S 2026-10-22 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-09-17Body height160 cm8302-2S
2026-09-17Body weight50 kg29463-7S
2026-09-17Body mass index (BMI) [Ratio]19.5 kg/m239156-5S
2026-09-17Systolic blood pressure118 mm[Hg]8480-6S
2026-09-17Diastolic blood pressure74 mm[Hg]8462-4S
2026-09-17Heart rate82 /min8867-4S
2026-09-17Respiratory rate14 /min9279-1S
2026-09-17Body temperature36.7 Cel8310-5S
2026-09-17Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-01Body height160 cm8302-2S
2026-10-01Body weight50 kg29463-7S
2026-10-01Body mass index (BMI) [Ratio]19.5 kg/m239156-5S
2026-10-01Systolic blood pressure116 mm[Hg]8480-6S
2026-10-01Diastolic blood pressure72 mm[Hg]8462-4S
2026-10-01Heart rate80 /min8867-4S
2026-10-01Respiratory rate14 /min9279-1S
2026-10-01Body temperature36.6 Cel8310-5S
2026-10-01Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-10-15Body height160 cm8302-2S
2026-10-15Body weight50.5 kg29463-7S
2026-10-15Body mass index (BMI) [Ratio]19.7 kg/m239156-5S
2026-10-15Systolic blood pressure114 mm[Hg]8480-6S
2026-10-15Diastolic blood pressure72 mm[Hg]8462-4S
2026-10-15Heart rate78 /min8867-4S
2026-10-15Respiratory rate14 /min9279-1S
2026-10-15Body temperature36.7 Cel8310-5S
2026-10-15Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-29Body height160 cm8302-2S
2026-10-29Body weight50.5 kg29463-7S
2026-10-29Body mass index (BMI) [Ratio]19.7 kg/m239156-5S
2026-10-29Systolic blood pressure116 mm[Hg]8480-6S
2026-10-29Diastolic blood pressure70 mm[Hg]8462-4S
2026-10-29Heart rate76 /min8867-4S
2026-10-29Respiratory rate14 /min9279-1S
2026-10-29Body temperature36.6 Cel8310-5S
2026-10-29Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-10-08Body height160 cm8302-2S
2026-10-08Body weight50 kg29463-7S
2026-10-08Body mass index (BMI) [Ratio]19.5 kg/m239156-5S
2026-10-08Systolic blood pressure118 mm[Hg]8480-6S
2026-10-08Diastolic blood pressure72 mm[Hg]8462-4S
2026-10-08Heart rate88 /min8867-4S
2026-10-08Respiratory rate16 /min9279-1S
2026-10-08Body temperature37.6 Cel8310-5S
2026-10-08Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-22Body height160 cm8302-2S
2026-10-22Body weight50.5 kg29463-7S
2026-10-22Body mass index (BMI) [Ratio]19.7 kg/m239156-5S
2026-10-22Systolic blood pressure114 mm[Hg]8480-6S
2026-10-22Diastolic blood pressure70 mm[Hg]8462-4S
2026-10-22Heart rate76 /min8867-4S
2026-10-22Respiratory rate14 /min9279-1S
2026-10-22Body temperature36.6 Cel8310-5S
2026-10-22Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Improve the PEG score by at least 30% from baseline2026-10-29activePEG fell from 7.3 to 5.3 by the six-week review, a 27% improvement; goal continued
Stand at the easel for 30 minutes at a time by the six-week review2026-10-29completedStands 25 to 30 minutes at the easel with the shoe lift
First opioid dose reduction, agreed by the patient, without loss of function2026-10-29completedReduced from 60 to 52.5 MME a day at the four-week visit; PEG and standing tolerance improved at the six-week review
Naloxone in the home with a family member trained to use it2026-09-17completedNaloxone nasal spray dispensed; spouse taught at the first visit

Interventions

InterventionStatusGuideline
Physical medicine and rehabilitation referral for a multimodal rehabilitation plan: exercise therapy, bracing and orthotic review, a shoe lift for the leg-length difference, and function goalscompletedGL-VADOD-LBP-2022, GL-ACP-LBP-2017
Nonopioid treatment first: duloxetine titrated to 60 mg daily, scheduled acetaminophen up to 3 g a day, and topical diclofenac for the anklecompletedGL-ACP-LBP-2017, GL-CDC-OPIOID-2022, GL-CMID-2026
Opioid risk mitigation: review benefits and harms together, check the prescription drug monitoring program, urine drug test with consent, prescribe naloxone 4 mg nasal spray and teach a family member, and avoid benzodiazepines and other sedativescompletedGL-CDC-OPIOID-2022
Collaborative, gradual opioid taper of about 10% of the dose a month, paused if pain or function worsens; never stop opioids abruptlycompletedGL-CDC-OPIOID-2022
Physical therapy twice weekly with graded exercise and aquatic therapy, pain neuroscience education, and cognitive behavioral therapy for chronic paincompletedGL-ACP-LBP-2017, GL-VADOD-LBP-2022
Measure pain and function with the PEG at every visit and depressive symptoms with the PHQ-9 every two to four weeks; complete a structured safety assessment if the PHQ-9 reaches 10 or item 9 is positivecompletedGL-CMID-2026, GL-CDC-OPIOID-2022
Check ALT periodically on regular acetaminophen, and replete vitamin DcompletedGL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Biography of Frida Kahlo (Ochoa Sandy G; edited and updated by Ximena Jordan) Museo Frida Kahlo, Mexico City other
SRC-0002 Courtney CA, O'Hearn MA, Franck CC. Frida Kahlo: Portrait of Chronic Pain. Phys Ther. 2017;97(1):90-96 Physical Therapy (PubMed 27562644) scholarly
SRC-0003 Budrys V. Neurological deficits in the life and works of Frida Kahlo. Eur Neurol. 2006;55(1):4-10 European Neurology (PubMed 16432301) scholarly
SRC-0004 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review.
provenance reviewnot_startedMuseo Frida Kahlo biography and two PubMed abstracts logged; roster era corrected from 19th Century to Early 20th Century.
safe messaging reviewnot_startedInjuries and death recorded without graphic detail; PHQ-9 below 10 with item 9 negative at every screen; late-life opioid use not recorded.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.